奥扎格雷钠联合舒血宁注射液治疗急性脑梗死的疗效观察

来源 :医药论坛杂志 | 被引量 : 0次 | 上传用户:a734266739
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
目的观察奥扎格雷钠联合舒血宁注射液治疗急性脑梗死的临床疗效。方法将符合病例入选标准的60例患者随机分为观察组、对照组。2组均给予阿司匹林、舒血宁注射液等常规治疗,观察组同时加用奥扎格雷钠80mg静脉滴注,每日2次。2组均以连续治疗2周为1个疗程,治疗1个疗程后观察临床疗效。结果观察组痊愈率为36.67%,对照组痊愈率为20.00%,2组相比差异有统计学意义(P<0.05);观察组总有效率为76.67%,对照组总有效率为66.67%,2组相比差异有统计学意义(P<0.05)。全血高、中、低切黏度,血浆黏度,红细胞压积,血小板最大聚集率2组治疗前后组内相比差异有统计学意义(P<0.05);2组治疗后组间相比差异亦有统计学意义(P<0.05)。2组治疗前神经功能缺损程度评分组间相比差异无统计学意义(P>0.05);治疗后第7d、第14d与治疗前相比差异有统计学意义(P<0.05);治疗后第14d 2组组间相比差异有计学意义(P<0.05)。结论奥扎格雷钠联合舒血宁注射液治疗急性脑梗死临床疗效显著,可改善血液流变学指标,改善神经缺损。 Objective To observe the clinical efficacy of sodium ozagrel combined with Shuxuening injection in the treatment of acute cerebral infarction. Methods Sixty patients who met the criteria of the case were randomly divided into observation group and control group. 2 groups were given aspirin, Shuxuening injection and other conventional treatment, the observation group plus Ozagrel sodium 80mg intravenous infusion, 2 times a day. The two groups were treated continuously for 2 weeks for a course of treatment, after a course of treatment observed clinical efficacy. Results The cure rate was 36.67% in the observation group and 20.00% in the control group. The difference between the two groups was statistically significant (P <0.05). The total effective rate was 76.67% in the observation group and 66.67% in the control group. The difference between the two groups was statistically significant (P <0.05). There were significant differences between the two groups before and after treatment (P <0.05), the difference between the two groups after treatment was also significant There was statistical significance (P <0.05). There was no significant difference between the two groups in the score of neurological deficit before treatment (P> 0.05), but the difference was statistically significant (P <0.05) between the 7th and 14th days after treatment. There was significant difference between the 14d 2 groups (P <0.05). Conclusion Ozagrel sodium combined with Shuxuening injection has obvious curative effect on acute cerebral infarction. It can improve hemorrheological indexes and improve nerve defect.
其他文献
目的 了解河南省胸科医院住院分离结核分枝杆菌的耐药情况,为临床指导用药.方法 对179例患者痰、气管镜灌洗液等标本培养出的结核分枝杆菌采用绝对浓度间接法,进行13种单一抗
从四个角度出发对施工项目的风险因素进行阐述,分析了施工项目风险的识别流程及其预测、评估的办法,提出了五种风险防范控制的方法以及风险发生后的处置对策.
目的 探讨分析先天性泪囊炎的病源学、影响因素及治疗方法.方法 统计分析30例先天性泪囊炎患儿的基本资料,设为观察组.并进行泪囊分泌物细菌培养、观察泪道治疗效果.随机从预
随着我国医药事业的蓬勃发展和我国执业药师制度的实施,药学专业人才和执业药师缺乏的矛盾日益突出[1].药学专业是一门实践性、应用性很强的学科,学科的特点决定了实验教学在
目的分析糖尿病视网膜病变(DR)的危险因素,为DR的防治提供依据。方法 150例2型糖尿病(T2DM)患者按有无DR分为糖尿病非视网膜病变组(NDR组)75例和糖尿病视网膜病变组(DR组)75
鸡西矿业集团公司张辰煤矿西三采区3
<正>现阶段的医疗纠纷具备了诉讼越来越多,涉及赔偿金额越来越大,纠纷处理越来越难的特征,医疗机构的正常工作秩序也因此受到严重影响。有关研究表明,2002年《医疗事故处理条
目的观察奥扎格雷钠联合甲钴胺治疗糖尿病周围神经病变(DPN)的临床疗效。方法80例糖尿病周围神经病变患者随机分为治疗组和对照组各40例。对照组给予甲钴胺500μg,肌肉注射,
目的 探讨厄贝沙坦联合美托洛尔治疗慢性心力衰竭的临床效果.方法 选择慢性心力衰竭患者147例,随机分为两组,观察组76例,对照组71例.对照组采用常规治疗,洋地黄、利尿药物、
目的探讨养血清脑颗粒联合西比灵治疗偏头痛的疗效。方法将130例临床确诊为偏头痛的患者随机分为2组,养血清脑颗粒联合西比灵组(治疗组)65例,单用西比灵组(对照组)65例。治疗